Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00691353 |
Cross - Sectional study requiring one visit at the investigators office for the data collection.
Condition |
---|
Bipolar Disorder |
Study Type: | Observational |
Study Design: | Case-Only, Cross-Sectional |
Official Title: | Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers |
Estimated Enrollment: | 540 |
Study Start Date: | April 2008 |
Study Completion Date: | July 2008 |
Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Target Group:Patients that suffer from Bipolar Disorder Type 1 who are treated with atypical antipsychotics as monotherapy or cotherapy with mood stabilizers
Inclusion Criteria:
Exclusion Criteria:
Greece | |
Research Site | |
AGRINIO, Greece | |
Research Site | |
ALEXANDROUPOLI, Greece | |
Research Site | |
ATHENS, Greece | |
Research Site | |
CRETE, Greece | |
Research Site | |
ELEFSINA, Greece | |
Research Site | |
IOANNINA, Greece | |
Research Site | |
KARDITSA, Greece | |
Research Site | |
KATERINI, Greece | |
Research Site | |
KOS, Greece | |
Research Site | |
KOZANI, Greece | |
Research Site | |
THIVA, Greece | |
Research Site | |
LARISA, Greece | |
Research Site | |
NAFPLIO, Greece | |
Research Site | |
PATRA, Greece | |
Research Site | |
PEIRAIAS, Greece | |
Research Site | |
RODOS, Greece | |
Research Site | |
SERRES, Greece | |
Research Site | |
THESSALONII, Greece | |
Research Site | |
THESSALONIKI, Greece | |
Research Site | |
LAMIA, Greece |
Principal Investigator: | Charalambos Touloumis, MD | Athens Psychiatric Hospital Greece |
Responsible Party: | AstraZeneca, SA Greece ( Dr Pontikis Panagiotis, MD Medical and Regulatory Affairs Director ) |
Study ID Numbers: | NIS-NGR-DUM-2008/1 |
Study First Received: | June 3, 2008 |
Last Updated: | December 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00691353 |
Health Authority: | Greece: National Organization of Medicines |
Bipolar Disorder antipsychotics social functioning mood stabilizers Bipolar Disorder Type I |
atypical antipsychotics monotherapy cotherapy mood stabilizers |
Affective Disorders, Psychotic Mental Disorders Bipolar Disorder Mood Disorders Psychotic Disorders |